Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
Haifeng Zhang(Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine), Chuanjie Wu(Capital Medical University), Yajun Lian(First Affiliated Hospital of Zhengzhou University), Yunqing Ma(Paragon Genomics (United States)), Caihong He(University of Science and Technology Beijing), Nanchang Xie(First Affiliated Hospital of Zhengzhou University), Yuan Chen
Cited by 170
Related Papers
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Evaluation of DNA microarray results with quantitative gene expression platforms
|Nature Biotechnology|2006|619
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies
|BMC Bioinformatics|2008|402
Disposable Nucleic Acid Biosensors Based on Gold Nanoparticle Probes and Lateral Flow Strip
|Analytical Chemistry|2009|346
Pulsed electroreduction of low-concentration nitrate to ammonia
|Nature Communications|2023|272